2019. An Open-Label Extension of Two Phase 3 Studies Evaluating Long-Term Efficacy of FMX101 4% Minocycline Foam for the Treatment of Acne Vulgaris. SKIN The Journal of Cutaneous Medicine. 3, (Nov. 2019), S1. DOI:https://doi.org/10.25251/skin.3.supp.1.